WEAK BUY

Are good at buying companies and synergizing. 7-11 would be a huge deal and ATD can unlock synergy. There's a question of ATD diluting shares to pay for the deal, but the deal will be creative and the PE will rise after the deal. Also, a government could block the deal on anti-monopoly grounds. This pullback is probably a good opportunity.

TOP PICK

Just bought it when shares were beat up. Their North American shares have sold this year, due to more competition, a product issue (a new fabric did not flatter customers and has been getting negative reviews), and they're focused on growth in China when the market won't touch anything to do with China. The PE has fallen from 30x to 19x. Strong margins that outpace their peers. They are innovative and one hit product away from success.

(Analysts’ price target is $341.08)
TOP PICK

They're trying to make more narrow-body airplanes, but suffer supply chain problems. So, they've guided down which impacted shares. But they have 10 years' backlog. The dip now is an opportunity.

(Analysts’ price target is $41.23)
TOP PICK

Benefits from lower interest rates and a new CEO. Last year, they cut the dividend (which is safe as its payout ratio falls) and have sold $1.6 billion of assets. Their NAV is $9/share. Their properties serve healthcare, so are stable.

(Analysts’ price target is $5.71)